Ticker: DNLI

Company: Denali Therapeutics Inc.

Person: VICKI L SATO, director

Transaction date: Sept. 3, 2024

Reporting date: Sept. 4, 2024

Average share price: 25.002337662337663

Sold 3080.0 shares for 77007.2